JP2005513014A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513014A5
JP2005513014A5 JP2003543603A JP2003543603A JP2005513014A5 JP 2005513014 A5 JP2005513014 A5 JP 2005513014A5 JP 2003543603 A JP2003543603 A JP 2003543603A JP 2003543603 A JP2003543603 A JP 2003543603A JP 2005513014 A5 JP2005513014 A5 JP 2005513014A5
Authority
JP
Japan
Prior art keywords
dosage unit
analog
range
present
suitable excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003543603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005513014A (ja
JP4852229B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2002/011862 external-priority patent/WO2003041716A1/en
Publication of JP2005513014A publication Critical patent/JP2005513014A/ja
Publication of JP2005513014A5 publication Critical patent/JP2005513014A5/ja
Application granted granted Critical
Publication of JP4852229B2 publication Critical patent/JP4852229B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003543603A 2001-11-14 2002-11-14 便秘の処置用のプロスタグランジンアナログを含む用量単位 Expired - Lifetime JP4852229B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33131601P 2001-11-14 2001-11-14
US60/331,316 2001-11-14
PCT/JP2002/011862 WO2003041716A1 (en) 2001-11-14 2002-11-14 Dosage unit comprising a prostaglandin analog for treating constipation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011117231A Division JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Publications (3)

Publication Number Publication Date
JP2005513014A JP2005513014A (ja) 2005-05-12
JP2005513014A5 true JP2005513014A5 (enExample) 2006-01-12
JP4852229B2 JP4852229B2 (ja) 2012-01-11

Family

ID=23293447

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003543603A Expired - Lifetime JP4852229B2 (ja) 2001-11-14 2002-11-14 便秘の処置用のプロスタグランジンアナログを含む用量単位
JP2011117231A Pending JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011117231A Pending JP2011201905A (ja) 2001-11-14 2011-05-25 便秘の処置用のプロスタグランジンアナログを含む用量単位

Country Status (14)

Country Link
US (3) US8097653B2 (enExample)
EP (2) EP1443938B1 (enExample)
JP (2) JP4852229B2 (enExample)
AR (3) AR037524A1 (enExample)
AT (1) ATE522218T1 (enExample)
BR (1) BR0214075A (enExample)
CA (1) CA2464420C (enExample)
CY (1) CY1115856T1 (enExample)
DK (2) DK1443938T3 (enExample)
ES (2) ES2368729T3 (enExample)
LU (1) LU92826I2 (enExample)
PT (2) PT1443938E (enExample)
TW (1) TWI331920B (enExample)
WO (1) WO2003041716A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US8114911B2 (en) * 2002-10-23 2012-02-14 Sucampo Ag Prostaglandin compounds for the treatment of obesity
ES2591252T3 (es) * 2002-12-27 2016-11-25 Sucampo Ag Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional
WO2005002588A1 (en) * 2003-07-03 2005-01-13 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
BRPI0608818A2 (pt) * 2005-03-07 2010-01-26 Univ Chicago uso de antagonista opióides para atenuação de proliferação e migração de células endoteliais
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
CN101198334B (zh) * 2005-04-12 2013-02-06 苏坎波公司 前列腺素化合物和质子泵抑制剂用于治疗肠胃病的联合应用
NZ570190A (en) 2006-01-24 2011-03-31 Sucampo Ag Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
JP4783794B2 (ja) * 2006-01-24 2011-09-28 株式会社アールテック・ウエノ 軟ゼラチンカプセル製剤
US20090030072A1 (en) 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
US20090012165A1 (en) * 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
JP5797655B2 (ja) * 2009-09-18 2015-10-21 アドラー・コーポレーション 消化管障害のためのオピオイド受容体アンタゴニストの使用
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5350141A (en) * 1976-10-18 1978-05-08 Ono Pharmaceut Co Ltd Stabilization of prostaglandin and prostaglandin analogues
GB1581886A (en) 1977-05-26 1980-12-31 May & Baker Ltd Prostanol derivatives
GB2210556B (en) * 1987-10-02 1991-07-17 Ueno Seiyaku Oyo Kenkyujo Kk The use of 15-keto-16-halo-prostaglandins in cathartic compositions
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
JPH0681728B2 (ja) 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
CA2027814C (en) 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030346C (en) 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
CA2030344C (en) 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
EP0455448B1 (en) * 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2046069C (en) 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
JP2938579B2 (ja) 1990-12-15 1999-08-23 株式会社上野製薬応用研究所 消化管壁保護剤
ATE141794T1 (de) * 1991-03-14 1996-09-15 R Tech Ueno Ltd Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
DK0554794T3 (da) * 1992-02-04 1999-04-26 Eisai Co Ltd Aminobenzoesyrederivater
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
DK0857718T3 (da) * 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
DE19717005A1 (de) * 1997-04-23 1998-10-29 Kennametal Inc Spannfutter für Rundlaufwerkzeuge
ATE401894T1 (de) * 1997-11-28 2008-08-15 Sucampo Ag Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonisten
US6492417B1 (en) 1997-12-22 2002-12-10 Alcon Manufacturing, Ltd. 11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists
PT1220849E (pt) 1999-10-15 2004-10-29 Sucampo Ag Composicao de compostos biciclicos e metodo para a sua estabilizacao
DE60139002D1 (de) 2000-04-06 2009-07-30 Sucampo Ag Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
ATE387204T1 (de) 2001-05-18 2008-03-15 Sucampo Ag Zusammensetzung mit induzierendem kathartischen effekt
MXPA04002006A (es) * 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
ES2591252T3 (es) * 2002-12-27 2016-11-25 Sucampo Ag Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional

Similar Documents

Publication Publication Date Title
JP2005513014A5 (enExample)
JP2003531118A5 (enExample)
JP2005533860A5 (enExample)
JP2006182786A5 (enExample)
CA2445145A1 (en) Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
IL160028A (en) Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy
JP2004508410A5 (enExample)
EP1797878A3 (en) Benzothiazole derivatives
JP2005508337A5 (enExample)
JP2003503449A5 (enExample)
JP2007176958A (ja) セチリジン及びプソイドエフェドリンを含む錠剤
CA2464420A1 (en) Dosage unit comprising a prostaglandin analog for treating constipation
MD523G2 (ro) Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
JP2004532828A5 (enExample)
JP2002509164A5 (enExample)
JP2001520994A5 (enExample)
CA2389032A1 (en) Preventive or therapeutic agents for inflammatory diseases of intestine
JP2002542281A (ja) あらゆる気分障害、適応障害または不安−抑うつ混合障害の治療または予防に有用な医薬の調製のためのサレドゥタントおよび医薬として許容されるその塩類の使用
JPH1036365A5 (enExample)
JP2005524666A5 (enExample)
JP2004514709A5 (enExample)
JP2005515155A5 (enExample)
JP2004512376A5 (enExample)
CA2544432A1 (en) Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
JPH02233613A (ja) ピペリジノアルカノール誘導体類用の液体製剤組成物